PATENT CLAIM ANALYSIS

Application Number: 15967110
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-02
Patent Classification: ["514", "255060"]

Abstract:
The present invention relates to pyrazine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I: wherein the variables are as defined herein.

Claim (Index 246):
The compound of  claim 245 , which is: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 91.0
- Lexical Diversity: 2.01562
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14467175', '12642447', '14223109', '13106476', '13106167']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7578869447736816
- 35 USC 102 Novelty (BERT): 0.5313556952841799
- Combined Prediction Score: 0.7352338198247315
- Mean Citation Score: 294.052296
- Max Citation Score: 309.7149
- Similarity Product: 184.34812420002223

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test